Reference number : 236-2017-2018-Q1-00416, amendment number : , agreement type : G, recipient legal name : Allingham, John S, recipient country : CA, recipient province : ON, recipient city : Kingston, recipient postal code : K7L 3N6, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 248750.0, agreement start date : 2017-04-01, agreement end date : 2020-03-31, description english : Development of antibody-drug conjugates that use actin-targeting warheads, description french : Development of antibody-drug conjugates that use actin-targeting warheads, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2019-20), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2019-20), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada